Kubota Kei, Kobayashi Naoki, Yabuta Masayuki, Ohara Motomu, Naito Toyohiro, Kubo Takuya, Otsuka Koji
Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan; Analytical and Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1 Shinomiya, Hiratsuka-shi, Kanagawa 254-0014, Japan.
Analytical and Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1 Shinomiya, Hiratsuka-shi, Kanagawa 254-0014, Japan.
J Pharm Biomed Anal. 2017 Jun 5;140:98-104. doi: 10.1016/j.jpba.2017.03.027. Epub 2017 Mar 18.
This report describes a novel, comprehensive approach to identifying a fragment peak of monoclonal antibody-A (mAb-A), detected by sodium dodecyl sulfate-capillary gel electrophoresis (SDS-cGE). The fragment migrated close to the internal standard (10kDa marker) of SDS-cGE and increased about 0.5% under a 25°C condition for 6 months. Generally, identification of fragments observed in SDS-cGE is challenging to carry out due to the difficulty of collecting analytical amounts of fractionations from the capillary. In this study, in-gel digestion peptide mapping and reversed phase liquid chromatography-mass spectrometry (RPLC-MS) were employed to elucidate the structure of the fragment. In addition, a Gelfree 8100 fractionation system was newly introduced to collect the fragment and the fraction was applied to the structural analysis of a mAb for the first time. These three analytical methods showed comparable results, proving that the fragment was a fraction of heavy chain HC1-104. The fragment contained complementarity determining regions (CDRs), which are significant to antigen binding, and thus would affect the efficacy of mAb-A. In addition, SDS-cGE without the 10kDa marker was demonstrated to clarify the increased amount of the fragment, and the experiment revealed that the fragment increases 0.2% per year in storage at 5°C. The combination of the three analytical methodologies successfully identified the impurity peak detected by SDS-cGE, providing information critical to assuring the quality and stability of the biotherapeutics.
本报告描述了一种新颖、全面的方法,用于鉴定通过十二烷基硫酸钠-毛细管凝胶电泳(SDS-cGE)检测到的单克隆抗体A(mAb-A)的片段峰。该片段迁移至接近SDS-cGE的内标(10 kDa标记物)处,在25°C条件下放置6个月后增加了约0.5%。一般来说,由于难以从毛细管中收集分析量的分级分离物,在SDS-cGE中观察到的片段鉴定具有挑战性。在本研究中,采用胶内消化肽图谱和反相液相色谱-质谱联用(RPLC-MS)来阐明该片段的结构。此外,新引入了Gelfree 8100分级分离系统来收集该片段,并且该分级分离物首次应用于单克隆抗体的结构分析。这三种分析方法显示出可比的结果,证明该片段是重链HC1-104的一个组分。该片段包含对抗原结合至关重要的互补决定区(CDR),因此会影响mAb-A的疗效。此外,已证明不含10 kDa标记物的SDS-cGE可阐明该片段增加的量,并且实验表明该片段在5°C储存时每年增加0.2%。这三种分析方法的组合成功鉴定了通过SDS-cGE检测到的杂质峰,为确保生物治疗药物的质量和稳定性提供了关键信息。